(SNGX) |
| 0 (0%) 10-12 13:52 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.40 |
| Resistance 1: | 0.38 |
| Pivot price: | 0.37 |
| Support 1: | 0.35 |
| Support 2: | 0.29 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.790 |
| Book Value | 0.310 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -84.9 |
| Return on Equity (ttm) | -241.6 |
Company news
Sun, 11 Oct 2026
SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month On Ebola Vaccine Optimism - Stocktwits
Fri, 02 Oct 2026
Soligenix Stock Price Forecast. Should You Buy SNGX? - StockInvest.us
Fri, 18 Sep 2026
Soligenix (SNGX) grants director 78,947 stock options at $0.38 - Stock Titan
Fri, 18 Sep 2026
New Soligenix (SNGX) director options vest through 2027 - Stock Titan
Wed, 12 Aug 2026
SNGX: Applying for Vaccine Development Funding for Ebola Vaccine - Yahoo Finance
Fri, 07 Aug 2026
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
